Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies-Reference-Cited by-同舟云学术

Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies

Published:2015-06-08 Issue:7 Volume:15 Page:4808-4813
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Krom Russell J.¹²³⁴,Bhargava Prerna¹⁵³,Lobritz Michael A.¹⁵³⁶,Collins James J.¹²⁵³

Affiliation:

1. Institute for Medical Engineering and Science, Department of Biological Engineering, and Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

2. Harvard-MIT Program in Health Sciences and Technology, Cambridge, Massachusetts 02139, United States

3. Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115, United States

4. Department of Molecular and Translational Medicine, Boston University, Boston, Massachusetts 02215, United States

5. Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States

6. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, United States

Funder

Wyss Institute for Biologically Inspired Engineering, Harvard University

Defense Threat Reduction Agency

Howard Hughes Medical Institute

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.5b01943

Reference29 articles.

1. Synthetic Biology Moving into the Clinic

2. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

3. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials

4. Dispersing biofilms with engineered enzymatic bacteriophage

5. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phagemid-based capsid system for CRISPR-Cas13a antimicrobials targeting methicillin-resistant Staphylococcus aureus;Communications Biology;2024-09-13

2. A Comprehensive Review on Phage Therapy and Phage-Based Drug Development;Antibiotics;2024-09-11

3. Efficient Broad-Spectrum Cyanophage Function Module Mining;Microorganisms;2024-08-02

4. Making the leap from technique to treatment — genetic engineering is paving the way for more efficient phage therapy;Biochemical Society Transactions;2024-05-08

5. Genetically Engineered Microorganisms and Their Impact on Human Health;International Journal of Clinical Practice;2024-03-09